Natick-based Boston Scientific Corp. has received approval from the U.S. Food and Drug Administration (FDA) on its new stent system designed to treat coronary heart disease.
Natick-based Boston Scientific Corp. has received approval from the U.S. Food and Drug Administration (FDA) on its new stent system designed to treat coronary heart disease.
